The Antiobesity Effects of Buginawa in 3T3-L1 Preadipocytes and in a Mouse Model of High-Fat Diet-Induced Obesity

Figure 6

The mechanism of Bugi. Bugi treatment effectively reduced lipid accumulation by modulating the levels of PPARγ, C/EBPα, and SREBP1 in the eWAT and liver tissue of HFD-induced mice, as well as 3T3-L1 cells.